Background: The biochemical mechanism of nicotine biodegradation is important.
Results: An NADH-dependent and FAD-containing hydroxylase (HspB) for nicotine degradation was purified and mechanistically characterized.
Conclusion: The hydroxylase is crucial for nicotine degradation by Pseudomonas putida.
Significance: The novel HspB provides a sound basis for future studies aimed at a better understanding of the molecular principles of nicotine degradation.
Keywords: Bacteria, Enzyme Mechanisms, Enzyme Purification, Enzymes, Microbiology, 6-Hydroxy-3-succinoyl-pyridine, Catabolism, Hydroxylase, Nicotine, Pseudomonas
Abstract
Nicotine, the main alkaloid produced by Nicotiana tabacum and other Solanaceae, is very toxic and may be a leading toxicant causing preventable disease and death, with the rise in global tobacco consumption. Several different microbial pathways of nicotine metabolism have been reported: Arthrobacter uses the pyridine pathway, and Pseudomonas, like mammals, uses the pyrrolidine pathway. We identified and characterized a novel 6-hydroxy-3-succinoyl-pyridine (HSP) hydroxylase (HspB) using enzyme purification, peptide sequencing, and sequencing of the Pseudomonas putida S16 genome. The HSP hydroxylase has no known orthologs and converts HSP to 2,5-dihydroxy-pyridine and succinic semialdehyde, using NADH. 18O2 labeling experiments provided direct evidence for the incorporation of oxygen from O2 into 2,5-dihydroxy-pyridine. The hspB gene deletion showed that this enzyme is essential for nicotine degradation, and site-directed mutagenesis identified an FAD-binding domain. This study demonstrates the importance of the newly discovered enzyme HspB, which is crucial for nicotine degradation by the Pseudomonas strain.
Introduction
The tobacco manufacturing process produces large quantities of dangerously toxic liquid, solid, and airborne wastes, which cause serious problems because nicotine is extremely toxic (1). In general, the removal of these pollutants from the environment via physicochemical and natural biological processes is relatively slow, unpredictable, or irreversibly toxic to the biosphere. Therefore, the main, if not the only, successful strategy to fight pollution is the use and manipulation of the detoxification abilities of living organisms (2, 3). Soil microorganisms, particularly bacteria of the genus Pseudomonas, can metabolize a broad range of toxic compounds, including nicotine (3–5). Thus far, two pathways have been postulated for nicotine degradation by bacteria. The pyridine pathway used by Arthrobacter oxidans starts with the hydroxylation of the pyridine ring, and the pyrrolidine ring is opened later (Fig. 1A). The genes and enzymes used by Arthrobacter are known (4).
The pyrrolidine pathway used by Pseudomonas spp. begins with the formation of a double bond in the pyrrolidine ring to give N-methylmyosmine. The double bond is hydrolyzed to produce pseudooxynicotine that is oxidized to give 3-succinoylpyridine and methylamine. The 3-succinoylpyridine is then hydroxylated to yield 6-hydroxy-3-succinoylpyridine (HSP),3 which is converted to 2,5-dihydroxy-pyridine (DHP) and succinate (6, 7) (Fig. 1B). HSP and DHP are useful precursors for chemical synthesis (8). In the human body, there are at least six different pathways for the metabolism of nicotine, one of which is similar to the pyrrolidine pathway used by Pseudomonas. The intermediate pseudooxynicotine is the direct precursor of a potent tobacco-specific lung carcinogen (6, 9, 10).
In addition, a novel pathway of nicotine degradation in a fungi strain was recently proposed, and it is different from bacterial degradation pathways (Fig. 1C) (11). In our previous work, a nic gene cluster encoding nicotine oxidoreductase (NicA) and HSP hydroxylase (HspA) from Pseudomonas putida S16 was cloned and expressed in Escherichia coli (6, 12). HspA (312 amino acids) was interesting because it had low amino acid identity to any proteins of known function (12, 13). The enzyme HspA activity was relatively low (0.75 μm min−1 DHP production mg−1 protein) (12, 13). It made us search for another, more active HSP hydroxylase.
In this study, we describe another HSP hydroxylase (HspB) that has low amino acid identity (10.9%) to HspA. The catalytic efficiency of HspB is higher than that of HspA (12). 18O2 labeling experiments gave direct evidence for the incorporation of oxygen from O2 into the DHP produced. The enzyme HspB contains FAD as a prosthetic group, depends on reduced NADH as coenzyme, acts on HSP, and consumes 1 mol of O2/mol of NADH. Deleting hspB but not hspA prevented nicotine catabolism by P. putida S16, demonstrating the importance of the newly discovered HspB. The work described here provides a sound basis for future studies aimed at a better understanding of the molecular principles of nicotine degradation.
EXPERIMENTAL PROCEDURES
Materials
l-(−)-Nicotine (99% purity) was obtained from Fluka Chemie GmbH. FAD and NADH were obtained from Sigma-Aldrich. 18O2 was from Shanghai Research Institute of Chemical Industry. DHP was from SynChem OHG. HSP was isolated and purified from the culture broth of strain S16 (8). Source 30Q, Source 15ISO, and Sephadex G-25, Mono Q 5/50 GL, and Sephacryl S-200 HR columns were from GE Healthcare.
Bacterial Strains and Culture Conditions
P. putida S16 was isolated and cultured at 30 °C in lysogenic broth (LB) medium containing 1 g liter−1 nicotine as described previously (14). E. coli cells were grown at 37 °C in LB medium, and kanamycin was used for selection at appropriate concentrations.
DNA Manipulation and Gene Isolation
DNA manipulation and transformation were performed according to standard procedures (15). Individual genes were isolated by PCR using template DNA from the corresponding microorganism. The primers are listed in Table 1.
TABLE 1.
Primer | Sequence (5′-3′) | Recombinant plasmid |
---|---|---|
hspB | 5′-caaccatggcaatgagcatgaaacagcgcgtaat-3′ | pET28a-hspB |
5′-cctgcgctcgagacagaaaggtttccatagtctctg-3′ | ||
hspB mutation | 1: 5′-atgagcatgaaacagcgcgtaattatcg-3′ | hspB mutant |
2: 5′-tctcgacgcacgaagctattgattaaccaatccccttcgacaat-3′ | ||
3: 5′-attgtcgaaggggattggttaatcaatagcttcgtgcgtcgaga-3′ | ||
4: 5′-cagaaaggtttccatagtctctggaa-3′ | ||
hspB deletion | 5′-gcaggaattcgtctgttcgggtagttcttgg-3′ | S16-hspB deletion |
5′-gatagtcgacgtaacgcgctggtgcattc-3′ | ||
hspA deletion | 5′-cagtgaattctcgaccctgaaaatccggac-3′ | S16-hspA deletion |
5′-gatagtcgacatggttggtttcctccctg-3′ |
Draft Genome Sequence of P. putida S16
Genomic DNA was sequenced using the Solexa GA platform located at the Helmholtz Center for Infection Research in Germany. The short reads were assembled using Velvet (16) and Edena (17) algorithms. Putative protein-coding regions were predicted by Glimmer 3.01 (18).
HspB Purification
HspB activity was determined at 25 °C by measuring NADH oxidation in a quartz cuvette at 340 nm (NADH, ϵ340 = 6220 m−1 cm−1) using a UV-visible 2550 spectrophotometer (Shimadzu, Kyoto, Japan). The assay mixture was composed of 1.0 mm HSP, 0.25 mm NADH, and 10 μm FAD in 50 mm Tris-HCl buffer, pH 8.0. The Tris-HCl buffer was made at 25 °C. The reaction was initiated by the addition of enzyme. One katal of enzyme activity represents the oxidation of 1 mol of NADH/second. All manipulations of purification of wild-type HspB were performed at 4 °C, and all chromatography steps were carried out using an ÄKTA purifier chromatography system (GE Healthcare). All buffers contained 1 mm DTT, 1 mm EDTA, and 10 μm FAD. The cells were resuspended in 50 mm Tris-HCl buffer, pH 8.0 (50 g of cell paste in 200 ml of buffer), and lysed by sonication (175 W, 20 min). The purification steps were as follows.
Ammonium Sulfate Precipitation
After centrifugation (12,000 × g, 30 min), the supernatant was partially precipitated by slowly adding saturated ammonium sulfate solution to a final concentration of 40% saturation at 4 °C. The precipitate was removed by centrifugation, and more saturated ammonium sulfate was added to 50% saturation. Precipitated proteins were collected, dissolved in Tris-HCl buffer (50 mm, pH 8.0), and dialyzed overnight in the same buffer at 4 °C for further purification.
First Anion Exchange Chromatography
After dialysis, the protein solution was applied to a 1.6 × 10-cm Source 30Q anion exchange column pre-equilibrated with Tris-HCl buffer (50 mm, pH 8.0), and eluted with a linear gradient of 0 to 1.0 m NaCl in the same buffer. HspB was eluted at a NaCl concentration of 0.2 m.
Hydrophobic Interaction Chromatography
Active fractions from the previous step were pooled and supplemented with ammonium sulfate to a final concentration of 30% saturation. The supernatant was loaded onto a Source 15ISO column (0.5 × 11 cm) pre-equilibrated with 30% ammonium sulfate solution in 50 mm Tris-HCl buffer, pH 8.0. HspB was eluted using a reverse linear ammonium sulfate gradient from 30 to 0%. Active fractions were obtained from 27 to 25% saturation, pooled, and desalted on a Sephadex G-25 column (1.6 × 2.5 cm) in 50 mm Tris-HCl buffer, pH 8.0. We note that a substantial loss of activity occurred when FAD was omitted from the buffers.
Second Anion Exchange Chromatography
The desalted enzyme solution was applied to a Mono Q column (0.5 × 5 cm), using the same equilibration and elution conditions as the first anion exchange chromatography step. Activity was detected in fractions containing 0.35 m NaCl, and the solution was concentrated by ultrafiltration. The 10-kDa ultrafiltration tube was purchased from Millipore (Millipore Corporation, Billerica, MA).
Gel Filtration
Finally, the concentrated solution was loaded onto a Sephacryl S-200 HR column (1.6 × 60 cm) pre-equilibrated with Tris-HCl buffer (50 mm, pH 8.0) containing 150 mm NaCl. HspB was eluted using the same buffer at 0.45 column volume. Purified enzyme fractions were stored at −20 °C until further use.
Electrophoresis and Cross-linking
SDS-PAGE was performed using a 12.5% gel in a MiniProtean III electrophoresis cell (Bio-Rad) (19). Native PAGE was performed using gradient gels with a polyacrylamide range from 5 to 12.5% to determine the composition of the enzyme solution. Cross-linking of enzyme subunits was carried out by adding glutaraldehyde to the enzyme solution (20). Glutaraldehyde (1.5 μl, 1%, w/v) was added to 60 μl of enzyme solution (4 g liter−1) and incubated for 12 h at room temperature.
NH2-terminal Amino Acid Sequence of HspB
The NH2-terminal amino acid sequence of the enzyme was determined using automated Edman degradation (Shanghai Ji Kang Corp., Shanghai, China).
HspB Cofactor Determination
The flavin cofactor of HspB was identified and quantitatively analyzed by HPLC (Agilent 1200 series; Hewlett-Packard Corp., Santa Clara, CA) as described previously (21). The protein-containing solution (1.4 g liter−1) was boiled for 3 min to isolate the cofactor, which was detected by HPLC equipped with an Eclipse XDB-C18 column (4.6 × 150 mm; particle size, 5 μm) and diode array detection. The eluent was 100 mm ammonium bicarbonate, 18% methanol. A solution of the same composition, excluding HSP hydroxylase, was also measured as a control because extra FAD was used during the entire purification procedure. Standard FAD solutions of 0.1, 0.2, 0.4, 0.6, and 1.0 mm were used for quantitative analysis and detected at 265 nm.
18O2 Incorporation
To confirm enzymatic decarboxylation and monooxygenation of HSP, 18O2 was incorporated into DHP, which was the reaction product. The reaction was performed in a flask sealed by a plug with two rubber tubes for gas flow. Tris-HCl buffer (50 mm, pH 8.0) containing 1.0 mm HSP, 0.25 mm NADH, and 10 μm FAD was injected into the flask. The air in the flask was replaced by a flow of continuous nitrogen gas. Next, 18O2 was injected, and enzyme solution was added to the buffer to initiate the reaction, which was then stopped by heating. As a control, another flask containing 16O2 from air was used. After precipitate removal by centrifugation (12,000 × g, 30 min), the supernatants were analyzed by direct insertion mass spectra recorded on an API 4000 LC-MS system (Applied Biosystems, Foster City, CA).
Oxygen Consumption
HspB oxygen consumption was measured polarographically using a Chlorolab 2 system (Hansatech Instruments, Norfolk, UK). The reaction mixture contained 1.0 mm HSP, 0.25 mm NADH, 10 μm FAD, 50 mm Tris-HCl buffer (pH 8.0) and an appropriate concentration of enzyme HspB. The reaction was completed after 1 min, and HSP consumption was measured by HPLC.
P. putida S16 Mutant (hspA and hspB) Gene Deletion
To delete the hspA and hspB genes in strain S16 by single homologous recombination, internal fragments were amplified by PCR and cloned into the polylinker region of pK18mob (Table 1). To transfer the pK18mob into strain S16, triparental filter mating was performed as described previously using E. coli DH5α as the donor strain, E. coli HB101 (pRK2013) as the helper strain, and strain S16 as the recipient strain (22). P. putida S16 exconjugants harboring disrupted genes were isolated on M9 minimal medium plates containing citrate and kanamycin after incubation at 30 °C for 12 h. All of the mutant strains were analyzed by PCR to confirm target gene disruption.
HspB Site-directed Mutagenesis
The GADGA motif was deleted using the recombinant PCR method; the primers are listed in Table 1. Wild-type and mutant hspB genes were subcloned separately between the NcoI-XhoI sites of the pET28a expression vector. The crude cell enzymatic activity was detected as described above.
Analytical Techniques
HSP and DHP were detected by HPLC and confirmed by direct-insertion mass spectra recorded on the API 4000 LC-MS system. HPLC analysis was performed with a mobile phase of the mixture of methanol and 1 mm acetic acid (25:75, v/v) at a flow rate of 0.5 ml min−1. MS analysis was performed in both negative and positive ion turbo ion spray ionization mode.
Succinic semialdehyde was detected by GC-MS (GCD 1800C; Hewlett Packard, Folsom, CA) equipped with a 50 m J&W DB-5MS column, operated at 140 °C. The injection port and detector were set at 260 and 280 °C, respectively. After the HspB enzyme reaction, the reaction mixture (1 ml) was evaporated to dryness at 50 °C under reduced pressure and dissolved in 200 μl of acetonitrile. The acetonitrile solution was transferred to a vial and dried under a stream of nitrogen. The residue was silylated by the addition of 200 μl of bis(trimethylsilyl)-trifluoroacetamide (Sigma-Aldrich) at 80 °C for 4 h. After drying under a stream of nitrogen, the sample was redissolved in acetonitrile. Samples were analyzed by GC-MS.
Nucleotide Sequence Accession Number
The nucleotide sequence reported in the present study has been deposited in GenBankTM under accession number GQ857548.
RESULTS AND DISCUSSION
Analysis of genes and biochemical characterization of nicotine catabolism enzymes forms a basis for rationally improving Pseudomonas strains employed in nicotine waste disposal (13, 23). The characterization of genes and gene products in nicotine degradation by Pseudomonas will lead to a full understanding of this catabolic activity. The previously studied HSP hydroxylase (HspA) had a relatively low specific activity, which made us search for another, more active HSP hydroxylase (12).
HspB Purification and hspB Identification
The HSP hydroxylase was assayed by measuring NADH oxidation. HspB was purified ∼250-fold in five steps with an overall yield of 30%, using conventional column chromatography (Table 2). HspB had a molecular mass of ∼40 kDa on SDS-PAGE (Fig. 2A) and 80 kDa when determined by native Sephacryl S-200 HR column chromatography or by native PAGE of the purified enzyme (Fig. 2B). SDS-PAGE of the enzyme solution treated with glutaraldehyde produced a strong band at 40 kDa and a weaker band at 80 kDa, indicating partial cross-linking (supplemental Fig. S1). These data suggest that HspB is a dimer.
TABLE 2.
Step | Total volume | Total protein | Total activity | Specific activity | Yield | Purification factor |
---|---|---|---|---|---|---|
ml | mg | nkat | nkat mg−1 | % | Fold | |
Crude extract | 190 | 2,380 | 2063 | 0.833 | 100 | 1 |
Ammonium sulfate treatment | 32.5 | 485 | 1511 | 3.17 | 73.3 | 4 |
Anion exchange I (Source 30Q) | 46.3 | 62.4 | 1400 | 22.5 | 67.9 | 27 |
Hydrophobic interaction (Source 15ISO) | 8.7 | 10.2 | 1258 | 123 | 61.0 | 148 |
Anion exchange II (Mono Q) | 1.2 | 5.6 | 1100 | 197 | 53.3 | 236 |
Gel filtration (Sephacryl S-200 HR) | 2.6 | 3.0 | 635 | 212 | 30.8 | 254 |
The NH2-terminal amino acid sequence of purified HspB was SMKQRVIIVG. The hspB gene sequence was identified by mining of the P. putida S16 draft sequence and comparing it with the NH2-terminal sequence of HspB. The newly discovered hspB gene is separated by more than 30 kb of DNA away from the nic gene cluster, which contains nicA and hspA (6, 12). The HspB gene product displays 10.9% amino acid identity with HspA (12). NCBI BLASTP analysis revealed the identity of HspB to p-nitrophenol monooxygenase from Pseudomonas sp. NyZ402 (41% amino acid identity) (24).
Prosthetic Group Identification
HspB is predicted to contain an FAD-binding domain (Pfam01494, amino acids 30–336) according to NCBI Blast. The HspB sequence was submitted to the mGenThreader server for fold assignment, and the protein structures with significant hits were chosen as templates for further modeling (Table S1). Five models were generated, and the one with the lowest discrete optimized protein energy score was chosen for visualization (Table S2). The three-dimensional structure is the NCBI-curated FAD domain in pfam01494 (supplemental Fig. S2, A and B). Further experimental evidences supported the involvement of FAD in the function of HspB. First, HspB UV-visible maximum absorbance at 382 and 452 nm with a minimum at 410 nm is characteristic of a flavoprotein (data not shown). Second, the three-dimensional plot of diode array detection data shows that the supernatant of the boiled enzyme solution exhibited absorption maxima at 265, 375, and 450 nm, identical to FAD (Fig. 2C). Third, the FAD concentration in purified HspB (33 μm) was 36 μm (calculated from the 265-nm peak), suggesting that each HspB subunit contains one FAD as a prosthetic group. Besides, the addition of FMN did not affect enzyme activity (data not shown). Based on further sequence analysis, we found a GADGA motif (amino acids 162–166) in the FAD-binding domain (supplemental Fig. S2C). The mutant hspB without the GADGA motif was inserted into pET28a and expressed in E. coli BL21(DE3). The transformant pET28a-hspB served as a positive control. No HspB activity of the transformant containing mutant hspB was detected in both cell free extract and resting cells. This result indicates the importance of the GADGA motif in the FAD-binding domain.
Characterization of HspB Reaction Conditions
Effect of pH on HspB stability
HspB activity was measured after overnight incubation at 25 °C in buffers with identical ionic strength (50 mm) at different pH. Citric acid-sodium citrate, Tris-HCl, and sodium carbonate-sodium bicarbonate buffers were used for incubation at pH 4.0–7.0, 7.0–9.0, and 9.0–11.0, respectively. The enzyme displayed maximal stability in Tris-HCl buffer (pH 8.0) (Fig. 3A). At pH below 7.0 or above 9.0, there was substantial loss of activity. Phosphate buffer (pH 6.0–8.0), which was used initially, clearly inhibited enzyme activity (not shown).
Effect of Temperature on HspB Stability
To assess temperature stability, HspB was incubated in Tris-HCl buffer (50 mm, pH 8.0) for 30 min at temperatures ranging from 5 to 40 °C. The enzyme activity measured at 5 °C was maintained up to ∼25 °C but was lost quickly at higher temperatures (Fig. 3B). The enzyme was stable for at least 1 week at 4 °C in Tris-HCl buffer and for several months frozen in the same buffer at −20 °C (not shown). Optimal pH and temperature for enzyme catalysis were pH 8 and 25 °C, respectively. The specific activity of the purified enzyme under optimal conditions was ∼4.8 μmol of NADH oxidized min−1 mg−1.
Effects of Metal Salts on HspB Activity
The effect of 11 metal salts at 2 mm (Na+, Ni2+, Co2+, Ca2+, Cu2+, Mn2+, Zn2+, Mg2+, K+, MoO42−42−, and WO42−) on HspB activity was examined. Cu2+ and Zn2+ completely abolished enzyme activity, but the other ions had minimal inhibitory effects (Fig. 3C), suggesting that HspB did not require a metal cofactor.
Characterization of HspB Reaction Mechanism
18O2 Labeling
The HspB reaction was performed in the presence of 18O2 to confirm the predicted incorporation of a single oxygen atom into DHP. The reaction products were analyzed by LC-MS. The fragmentation pattern was consistent with the incorporation of one 18O into DHP at position 5 (Fig. 4).
HspB Reaction Product “Succinic Semialdehyde” Detection
After derivatization by silanization, the product of the HspB reaction was analyzed by GC-MS. The molecular ion peak is at m/z 174, and featured fragments are at m/z 29 ([CHO]+), 45 ([COOH]+), 89 ([Si(CH3)3O]+), and 73 ([(CH2)2COOH]+) (Fig. 5).
Reaction Kinetics of HspB
HSP concentration was 0.2 mm when we measured the Km for NADH. The concentration for NADH was 0.25 mm when we measured the Km for HSP. Kinetic constants for the enzyme showed apparent Km = 0.175 mm, kcat = 2.0 s−1 for HSP in the presence of NADH, and no detectable activity in the presence of NADPH. HSP acts as an initial effector and strongly stimulates NADH oxidation by HspB (apparent Km = 0.104 mm).
HSP Oxidation Stoichiometry
The reaction stoichiometry of HSP oxidation by HspB was calculated from NADH consumption, oxygen consumption (Fig. 3D), and HSP degradation. The ratio of oxygen (0.64 μmol) consumption and NADH (1.3 μmol) oxidation was 1:2. HSP degradation was measured by HPLC, and ∼0.89 μmol of HSP was consumed for each 0.74 μmol of NADH oxidized. Therefore, the ratio of NADH used for HSP oxidation was ∼1:1 (Fig. 6).
Deletion of hspA and hspB Genes
The hspA and hspB genes were deleted separately, and the related cell growth and resting cell reactions were all performed. The hspA gene deletion mutant could grow well in nicotine medium as the same as wild-type strain S16, whereas the hspB gene deletion mutant could not grow in nicotine medium (Fig. 7A). Cells of hspA and hspB gene deletion mutants were harvested in the mid-growth phase by centrifugation at 6,000 × g for 10 min at 4 °C, washed three times with 0.02 m sodium phosphate buffer (pH 7), and suspended in the same buffer at 5 of A600 nm (called resting cells). Resting cells of hspA and hspB gene deletion mutants could both transform nicotine (Fig. 7B) to HSP. In addition, resting cells of hspB gene deletion mutant could not degrade HSP, different from hspA gene deletion mutant and strain S16 (Fig. 7C). The above facts indicate that HspB is crucial for HSP transformation and nicotine degradation by the strain. Isoenzymes present in bacteria are thought to be involved in substrate distribution as well as reducing equivalents among different intracellular compartments (25). Additionally, the hspA and hspB genes are located in different gene clusters. We propose that these two enzymes may be isoenzymes coexisting in the same cell. The HspB enzymatic mechanism might be similar to the oxidative decarboxylation reaction of 6-hydroxynicotinate catalyzed by 6-hydroxynicotinate 3-monooxygenase, depending on O2, NADH, and FAD, except that HspB cannot degrade 6-hydroxynicotinate (26).
In summary, a novel hydroxylase was purified and mechanistically characterized, and the gene encoding the enzyme was identified. This study demonstrates the importance of the discovered enzyme that is crucial for nicotine degradation by the Pseudomonas strain.
Supplementary Material
Acknowledgments
We thank Dr. Tobias Kieser (John Innes Centre, Norwich, UK) and two anonymous reviewers for very helpful comments on the manuscript. We also acknowledge Dr. Helmut Bloecker for draft genome sequencing at the Helmholtz Center for Infection Research (Braunschweig, Germany).
This work was supported in part by Chinese National Natural Science Foundation Grants 30900042 and 30821005 and from Ministry of Science and Technology of China National Basic Research Program Grant 2009CB118906. This work was also supported by Key Basic Research Program of Shanghai Grant 09JC1407700 and Grant 10CG10 from the Chen Guang Project from the Shanghai Municipal Education Commission and the Shanghai Education Development Foundation.
The on-line version of this article (available at http://www.jbc.org) contains supplemental text, Tables S1 and S2, and Figs. S1 and S2.
- HSP
- 6-hydroxy-3-succinoylpyridine
- DHP
- 2,5-dihydroxy-pyridine.
REFERENCES
- 1. Novotny T. E., Zhao F. (1999) Tob. Control 8, 75–80 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Díaz E., Ferrández A., Prieto M. A., García J. L. (2001) Microbiol. Mol. Biol. Rev. 65, 523–569 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Díaz E. (2004) Int. Microbiol. 7, 173–180 [PubMed] [Google Scholar]
- 4. Brandsch R. (2006) Appl. Microbiol. Biotechnol. 69, 493–498 [DOI] [PubMed] [Google Scholar]
- 5. Eberhardt H. (1995) Beitr. Tabakforsch. Int. 16, 119–129 [Google Scholar]
- 6. Tang H., Wang L., Meng X., Ma L., Wang S., He X., Wu G., Xu P. (2009) Appl. Environ. Microbiol. 75, 772–778 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Wang S. N., Liu Z., Tang H. Z., Meng J., Xu P. (2007) Microbiol. SGM 153, 1556–1565 [DOI] [PubMed] [Google Scholar]
- 8. Wang S. N., Xu P., Tang H. Z., Meng J., Liu X. L., Qing C. (2005) Environ. Sci. Technol. 39, 6877–6880 [DOI] [PubMed] [Google Scholar]
- 9. Hecht S. S., Hochalter J. B., Villalta P. W., Murphy S. E. (2000) Proc. Natl. Acad. Sci. U.S.A. 97, 12493–12497 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Hukkanen J., Jacob P., 3rd, Benowitz N. L. (2005) Pharmacol. Rev. 57, 79–115 [DOI] [PubMed] [Google Scholar]
- 11. Meng X. J., Lu L. L., Gu G. F., Xiao M. (2010) Res. Microbiol. 161, 626–633 [DOI] [PubMed] [Google Scholar]
- 12. Tang H., Wang S., Ma L., Meng X., Deng Z., Zhang D., Ma C., Xu P. (2008) Appl. Environ. Microbiol. 74, 1567–1574 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Li H., Li X., Duan Y., Zhang K. Q., Yang J. (2010) Appl. Microbiol. Biotechnol. 86, 11–17 [DOI] [PubMed] [Google Scholar]
- 14. Wang S. N., Xu P., Tang H. Z., Meng J., Liu X. L., Huang J., Chen H., Du Y., Blankespoor H. D. (2004) Biotechnol. Lett. 26, 1493–1496 [DOI] [PubMed] [Google Scholar]
- 15. Sambrook J., Russell D. W. (2001) Molecular Cloning: A Laboratory Manual, 3rd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY [Google Scholar]
- 16. Zerbino D. R., Birney E. (2008) Genome Res. 18, 821–829 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Hernandez D., François P., Farinelli L., Osterås M., Schrenzel J. (2008) Genome Res. 18, 802–809 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Delcher A. L., Harmon D., Kasif S., White O., Salzberg S. L. (1999) Nucleic Acids Res. 27, 4636–4641 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Laemmli U. K. (1970) Nature 227, 680–685 [DOI] [PubMed] [Google Scholar]
- 20. Griffith I. P. (1972) Biochem. J. 126, 553–560 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Eppink M. H., Boeren S. A., Vervoort J., van Berkel W. J. (1997) J. Bacteriol. 179, 6680–6687 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Tao F., Yu B., Xu P., Ma C. Q. (2006) Appl. Environ. Microbiol. 72, 4604–4609 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Civilini M., Domenis C., Sebastianutto N., Bertoldi M. (1997) Waste Manag. Res. 15, 349–358 [Google Scholar]
- 24. Wei Q., Liu H., Zhang J. J., Wang S. H., Xiao Y., Zhou N.Y. (2010) Biodegradation 21, 575–584 [DOI] [PubMed] [Google Scholar]
- 25. Hunter G. R., Hellman U., Cazzulo J. J., Nowicki C. (2000) Mol. Biochem. Parasitol. 105, 203–214 [DOI] [PubMed] [Google Scholar]
- 26. Nakano H., Wieser M., Hurh B., Kawai T., Yoshida T., Yamane T., Nagasawa T. (1999) Eur. J. Biochem. 260, 120–126 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.